Detalles de la búsqueda
1.
Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4).
Mod Rheumatol
; 34(3): 453-465, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37319017
2.
Determining the late effect parameter in the Fleming-Harrington test using asymptotic relative efficiency in cancer immunotherapy clinical trials.
J Biopharm Stat
; : 1-20, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37585719
3.
Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2).
Mod Rheumatol
; 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103258
4.
Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4).
Mod Rheumatol
; 33(1): 73-80, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267027
5.
Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis.
Mod Rheumatol
; 32(4): 696-707, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850095
6.
A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years.
Mod Rheumatol
; 32(4): 708-717, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918131
7.
Population pharmacokinetic analysis of peficitinib in patients with rheumatoid arthritis.
Br J Clin Pharmacol
; 87(4): 2014-2022, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068028
8.
A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years.
Mod Rheumatol
; 31(3): 543-555, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050760
9.
A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
Eur J Clin Pharmacol
; 76(8): 1135-1141, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32472157
10.
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.
Ann Rheum Dis
; 78(10): 1305-1319, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350269
11.
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).
Ann Rheum Dis
; 78(10): 1320-1332, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350270
12.
FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA.
Retina
; 39(7): 1289-1298, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746414
13.
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations.
Cancer Sci
; 109(9): 2852-2862, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29972716
14.
Association between matrix metalloprotease-3 levels and radiographic progression in patients with RA: a post hoc analysis from a Japanese phase 3 clinical trial of peficitinib (RAJ4).
Mod Rheumatol
; 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37902304
15.
SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA.
Retina
; 37(6): 1055-1064, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27755380
16.
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study.
Ann Rheum Dis
; 75(6): 1057-64, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26672064
17.
Pharmacokinetics and Safety of Single and Multiple Doses of Peficitinib (ASP015K) in Healthy Chinese Subjects.
Drug Des Devel Ther
; 16: 1365-1381, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35586186
18.
Validation of Soft Labels in Developing Deep Learning Algorithms for Detecting Lesions of Myopic Maculopathy From Optical Coherence Tomographic Images.
Asia Pac J Ophthalmol (Phila)
; 11(3): 227-236, 2022 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937047
19.
Exposure-response modeling of peficitinib efficacy in patients with rheumatoid arthritis.
Pharmacol Res Perspect
; 9(3): e00744, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929089
20.
The Bioequivalence of Two Peficitinib Formulations, and the Effect of Food on the Pharmacokinetics of Peficitinib: Two-Way Crossover Studies of a Single Dose of 150 mg Peficitinib in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 10(3): 283-290, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32618438